Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRNA Moderna, Inc.

休市中 04-02 16:00:00 EDT

49.20

-0.83

-1.66%

盘后49.38

+0.18+0.37%

19:56 EDT

最高50.51	最低48.11	成交量463.18万
今开48.15	昨收50.03	日振幅4.80%
总市值194.31亿	流通市值178.74亿	总股本3.95亿
成交额2.27亿	换手率1.27%	流通股本3.63亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRNA","market":"US","secType":"STK","nameCN":"Moderna, Inc.","latestPrice":49.2,"timestamp":1775160000000,"preClose":50.03,"halted":0,"volume":4631750,"hourTrading":{"tag":"盘后","latestPrice":49.38,"preClose":49.2,"latestTime":"19:56 EDT","volume":124851,"amount":6145375.9479,"timestamp":1775174213239,"change":0.18,"changeRate":0.003659,"amplitude":0.008943},"delay":0,"changeRate":-0.016590045972416517,"floatShares":363290461,"shares":394939400,"eps":-7.26,"marketStatus":"休市中","change":-0.83,"latestTime":"04-02 16:00:00 EDT","open":48.145,"high":50.51,"low":48.11,"amount":226691198.33525002,"amplitude":0.047971,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.26,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1775462400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1544158800000,"exchange":"NASDAQ","adjPreClose":50.03,"preHourTrading":{"tag":"盘前","latestPrice":48.33,"preClose":50.03,"latestTime":"09:29 EDT","volume":17257,"amount":844178.840621,"timestamp":1775136599965,"change":-1.7,"changeRate":-0.03398,"amplitude":0.025441},"postHourTrading":{"tag":"盘后","latestPrice":49.38,"preClose":49.2,"latestTime":"19:56 EDT","volume":124851,"amount":6145375.9479,"timestamp":1775174213239,"change":0.18,"changeRate":0.003659,"amplitude":0.008943},"volumeRatio":0.7255457037517518,"optionData":{"bulkOrders":[{"symbol":"MRNA","call":true,"expireDate":1775793600000,"strike":"50.0","timestamp":1775138186607,"price":1.52,"volume":5888,"amount":894976,"type":"-"},{"symbol":"MRNA","call":true,"expireDate":1775102400000,"strike":"56.0","timestamp":1775138186607,"price":0.25,"volume":5888,"amount":147200,"type":"-"}]},"impliedVol":0.8059,"impliedVolPercentile":0.6534},"requestUrl":"/m/hq/s/MRNA","defaultTab":"news","newsList":[{"id":"2618973837","title":"莫德纳盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618973837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618973837?lang=zh_cn&edition=full","pubTime":"2026-03-11 23:09","pubTimestamp":1773241765,"startTime":"0","endTime":"0","summary":"北京时间2026年03月11日23时09分，莫德纳股票出现波动，股价快速上涨5.04%。截至发稿，该股报57.75美元/股，成交量250.671万股，换手率0.63%，振幅5.35%。莫德纳股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Acurx Pharmaceuticals, Inc.、天演药业、Ocugen, Inc.涨幅较大，Acurx Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.、Quince Therapeutics, Inc.较为活跃，换手率分别为1506.86%、1019.35%、62.59%，振幅较大的相关个股有Acurx Pharmaceuticals, Inc.、Kala Bio, Inc.、天演药业，振幅分别为58.62%、50.19%、41.98%。截至 2025 年 8 月，莫德纳有 35 种 mRNA 开发候选药物处于临床研究中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603112309259548dd23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603112309259548dd23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4533","MRNY","BK4534","BK4568","MRNA","BK4501","BK4139","BK4548","BK4588","MRNX","BK4585","BK4532","BK4551"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1148455518","title":"异动解读 | Moderna盘中大跌5.06%，因宣布支付9.5亿美元大额款项","url":"https://stock-news.laohu8.com/highlight/detail?id=1148455518","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148455518?lang=zh_cn&edition=full","pubTime":"2026-03-06 01:05","pubTimestamp":1772730319,"startTime":"0","endTime":"0","summary":"生物技术公司Moderna, Inc. (MRNA) 今日盘中股价大幅下跌5.06%，引起了市场的关注。消息面上，Moderna宣布，已承诺在2026年7月8日或之前，向合作方Arbutus Biopharma及其子公司Genevant Sciences支付一笔总额高达9.5亿美元的无条件一次性款项。市场分析认为，这笔大额支出可能对公司的现金流和短期财务表现构成压力，从而引发了投资者的担忧和抛售。值得注意的是，尽管有分析师（贝伦贝格）在近期将其目标价从32美元上调至45美元，显示出对其长期前景的看好，但今日股价的剧烈波动主要反映了市场对上述大额支付事件的即时反应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199935387","title":"Moderna将于2026年7月8日前向Arbutus/Genevant支付9.5亿美元无条件一次性款项","url":"https://stock-news.laohu8.com/highlight/detail?id=1199935387","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199935387?lang=zh_cn&edition=full","pubTime":"2026-03-05 19:10","pubTimestamp":1772709057,"startTime":"0","endTime":"0","summary":"生物技术巨头Moderna, Inc.宣布，其已承诺在2026年7月8日或之前，向合作方Arbutus Biopharma及其子公司Genevant Sciences支付一笔总额高达9.5亿美元的无条件一次性款项。此次支付不附带任何后续条件，标志着双方在相关技术平台合作上的一个重要财务里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","BK4568","BK4532","BK4551","BK4534","BK4585","BK4501","BK4588","BK4533","BK4139","MRNX","MRNA","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144697251","title":"ETF日报｜三倍做多半导体ETF涨近6%；纳指三倍做多ETF涨超4%；加密与半导体产品相对跑赢","url":"https://stock-news.laohu8.com/highlight/detail?id=1144697251","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144697251?lang=zh_cn&edition=full","pubTime":"2026-03-05 09:12","pubTimestamp":1772673133,"startTime":"0","endTime":"0","summary":"美股ETF涨幅Top5$2倍做多GEMI ETF-Leverage Shares$上涨65.93%。该产品两倍做多Galaxy Digital，因公司股价上涨，杠杆效应放大当日涨幅。大盘指数ETF涨幅Top 5$纳指三倍做多ETF$上涨4.49%。$三倍做多MSCI新兴市场ETF-Direxion$上涨2.92%。该产品三倍做多美国小盘股指数，指数当日上行使杠杆产品录得涨幅。该产品三倍做多半导体板块，芯片股集体走强推动杠杆产品上行。该产品配置不动产优先股，相关资产价格上行推动产品上涨。","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d8aa0ef7daa8f62604f5dfb5c1b0be1b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861220207.SGD","QLD","NBIZ","BK4588","PFFR","EWP","CONI","BK4596","MSTR","BK4539","USO","LU2360107671.USD","COIN","BKLN","SRLN","LU1861559042.SGD","BK4516","ASTN","BK4551","IREZ","LU1861217088.USD","MRNA","TQQQ","BK4600","ICVT","SOXL","BK4595","UPXI","ASTS","BK4554","NBIS","UCO","GEMG","PXIU","BK4535","EDC","BK4112","CWB","UGL","FAS","XLY","TNA","SMH","BK4585","DGP","GLXY","IREN","GEMI","BK4550","IYZ","GLXU","GLGG","LU1861558580.USD","MRNX","SMST","AGQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616559787","title":"莫德纳(MRNA)股价上涨14%，创2024年11月以来盘中新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2616559787","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616559787?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:44","pubTimestamp":1772635499,"startTime":"0","endTime":"0","summary":"莫德纳(MRNA)股价上涨14%，创2024年11月以来盘中新高","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603043662053278.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603043662053278.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","BK4568","BK4139","BK4532","MRNY","MRNA","MRNX","BK4501","BK4533","BK4551","BK4548","BK4534","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616559337","title":"莫德纳盘初股价上涨近14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616559337","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616559337?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:39","pubTimestamp":1772635171,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4533","BK4548","BK4501","BK4551","BK4534","BK4532","MRNA","BK4585","MRNX","MRNY","BK4588","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132841899","title":"Moderna股价盘前飙升3.7% 公司同意支付高达22.5亿美元和解新冠疫苗专利纠纷","url":"https://stock-news.laohu8.com/highlight/detail?id=1132841899","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132841899?lang=zh_cn&edition=full","pubTime":"2026-03-04 17:10","pubTimestamp":1772615446,"startTime":"0","endTime":"0","summary":"Moderna, Inc. (MRNA) 股价在盘前交易中强势上涨3.7%，此前该公司宣布已达成协议，将支付最高22.5亿美元，以了结与其新冠疫苗相关的专利纠纷。这一重大和解协议消除了笼罩在该公司头顶的一大不确定性，为市场注入了积极情绪。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8a24082c651a012a7802d63b3e7455d1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","MRNY","BK4534","BK4501","BK4139","BK4533","BK4551","BK4585","BK4588","BK4548","BK4568","MRNA","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112169372","title":"美股夜盘 | Moderna涨超8%；GitLab绩后跌超7%；部分油气股回落，美国能源跌超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1112169372","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112169372?lang=zh_cn&edition=full","pubTime":"2026-03-04 09:18","pubTimestamp":1772587093,"startTime":"0","endTime":"0","summary":"3月4日，美股夜盘时段，$Moderna(MRNA)$涨超8%，宣布与$Arbutus Biopharma(ABUS)$和Genevant Sciences就专利诉讼达成和解； 半导体初创公司$Mobix Labs(MOBX)$续涨4%，上一交易日暴涨532%；$GitLab(GTLB)$跌超7%，2026财年第四季度营收同比增长23%，2027财年业绩指引不及预期。部分油气股回落，$美国能源(USEG)$跌超7%，$Battalion Oil(BATL)$跌超8%。","market":"us","thumbnail":"https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"01f5bfa22fdb97a398b7c372534f3289","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4585","BK4581","BK4550","BK4535","BK4588","MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616306583","title":"专利纠纷靴子即将落地 mRNA领军者Moderna(MRNA.US)转身冲向“AI+医疗”浪潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2616306583","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616306583?lang=zh_cn&edition=full","pubTime":"2026-03-04 08:46","pubTimestamp":1772585185,"startTime":"0","endTime":"0","summary":"Moderna将在第三季度支付9.5亿美元，且未来无需再支付任何专利使用费。对于Moderna增长前景而言，如果彻底摆脱专利诉讼，进而无需再支付任何专利使用费，意味着该公司有望将增长重点与研发管道全面转向“AI+医疗”超级大浪潮。Moderna 将成为“AI+医疗”浪潮的下一个爆发标的?Moderna非常有机会把“AI+医疗”真正做成核心估值引擎，尤其是在个体化肿瘤疫苗和平台化 mRNA 药物开发上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409749.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4568","MRNY","BK4585","BK4534","MRNA","BK4533","BK4501","BK4532","BK4139","159891","BK4588","BK4551","BK4548","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143945821","title":"Moderna预计2026年第一季度将因和解支付计入9.5亿美元费用","url":"https://stock-news.laohu8.com/highlight/detail?id=1143945821","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143945821?lang=zh_cn&edition=full","pubTime":"2026-03-04 05:19","pubTimestamp":1772572752,"startTime":"0","endTime":"0","summary":"生物技术巨头Moderna近日披露，公司预计在2026年第一季度财务报表中确认一笔高达9.5亿美元的费用。这笔巨额支出与一项重大和解协议的支付义务直接相关，反映出公司在法律及商业纠纷解决方面面临的财务影响。该费用的确认将遵循美国通用会计准则（GAAP）的要求，并对当期利润产生显著影响。分析人士指出，此次预提费用虽可能短期压制股价，但彻底解决历史遗留问题有助于Moderna更专注于mRNA技术管线的战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MRNA","BK4532","BK4548","BK4568","MRNX","MRNY","BK4501","BK4588","BK4534","BK4585","BK4551","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140512903","title":"Moderna最新预测：2026年末现金及现金等价物预计达45-50亿美元区间","url":"https://stock-news.laohu8.com/highlight/detail?id=1140512903","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140512903?lang=zh_cn&edition=full","pubTime":"2026-03-04 05:19","pubTimestamp":1772572752,"startTime":"0","endTime":"0","summary":"Moderna, Inc. (MRNA) 最新更新了其财务展望，宣布将2026年末的现金及现金等价物预期调整至45亿至50亿美元的范围。这一修正后的预测反映了公司对其未来现金流状况的重新评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4534","BK4139","BK4501","BK4532","BK4568","BK4548","BK4551","MRNY","BK4588","MRNX","MRNA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120259381","title":"Moderna赢得欧盟对mRNA新冠-流感联合疫苗的支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1120259381","media":"老虎资讯综合","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120259381?lang=zh_cn&edition=full","pubTime":"2026-02-27 19:54","pubTimestamp":1772193265,"startTime":"0","endTime":"0","summary":"联合疫苗是Moderna摆脱对单一新冠疫苗依赖、实现业务增长战略的重要组成部分。在一项后期临床试验中，Moderna将接种其联合疫苗的人群，与在同一次就诊中分别接种竞争对手流感疫苗及Moderna新冠疫苗的人群进行比较。结果显示，在50岁及以上成年人中，Moderna的联合疫苗针对两种病毒所产生的免疫反应均高于已获批的流感和新冠疫苗。","market":"us","thumbnail":"https://static.tigerbbs.com/0600218936ae0bee3ba761a283aa6f69","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/0600218936ae0bee3ba761a283aa6f69"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Moderna赢得欧盟对mRNA新冠-流感联合疫苗的支持","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613730353","title":"Piper Sandler上调莫德纳目标价至69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613730353","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613730353?lang=zh_cn&edition=full","pubTime":"2026-02-23 14:40","pubTimestamp":1771828834,"startTime":"0","endTime":"0","summary":"格隆汇2月23日｜Piper Sandler将莫德纳目标价从63美元上调至69美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223144112a7151e48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223144112a7151e48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","BK4585","BK4568","BK4501","BK4548","BK4532","BK4551","MRNA","BK4139","BK4533","MRNX","MRNY","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612287922","title":"BioNTech控告Moderna侵犯新冠疫苗专利","url":"https://stock-news.laohu8.com/highlight/detail?id=2612287922","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612287922?lang=zh_cn&edition=full","pubTime":"2026-02-20 03:26","pubTimestamp":1771529160,"startTime":"0","endTime":"0","summary":"德国生物制药公司BioNTech周四在特拉华州联邦法院起诉Moderna，指控Moderna的新冠疫苗 mNEXSPIKE侵犯了BioNTech和辉瑞公司的竞争性疫苗Comirnaty的相关专利。　　该诉讼称，Moderna公司于2025年获得美国食品药品管理局批准的下一代新冠疫苗mNEXSPIKE，侵犯了BioNTech公司在用于简化mRNA疫苗设计的技术方面的权利，该技术允许以较低剂量为患者接种。　　Moderna在2022年起诉BioNTech及其合作伙伴辉瑞公司侵犯了Comirnaty的专利权，目前诉讼仍在进行中。","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-20/doc-inhnkyhw6558658.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MRNY","MRNX","MRNA","BNTX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1102127485","title":"异动解读 | FDA立场转变改善流感疫苗监管前景，Moderna盘中大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102127485","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102127485?lang=zh_cn&edition=full","pubTime":"2026-02-20 02:59","pubTimestamp":1771527578,"startTime":"0","endTime":"0","summary":"Moderna, Inc.  今日盘中股价大幅上涨5.06%，引起了市场的广泛关注。消息面上，美国食品和药物管理局改变了方针，将审查Moderna新型流感疫苗mRNA-1010的修订申请。此前一周，FDA曾拒绝了该疫苗的申请，引发了市场担忧，而此次立场的迅速反转显著改善了该疫苗的监管前景。多家券商随即更新了观点，其中William Blair将Moderna流感疫苗获得监管成功的概率从10%大幅提高到55%。RBC Capital Markets认为，FDA的迅速反转符合当前政策模式。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","MRNY","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612405943","title":"莫德纳mRNA流感疫苗获FDA受理，计划2026年流感季使用","url":"https://stock-news.laohu8.com/highlight/detail?id=2612405943","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612405943?lang=zh_cn&edition=full","pubTime":"2026-02-19 04:11","pubTimestamp":1771445460,"startTime":"0","endTime":"0","summary":"2026年2月19日消息，莫德纳采用mRNA技术的流感疫苗上市申请已获FDA受理，审批截止日期为2026年8月1日。此前FDA曾以临床试验设计存在缺陷为由拒绝受理，后改变立场同意审核。为加速获批，莫德纳提出分年龄段监管路径，为50至64岁人群寻求常规批准，为65岁及以上人群寻求加速批准，并承诺在老年人群中开展追加研究。若顺利获批，该疫苗计划于2026年晚些时候的流感季面向老年人群使用。以上内容基于公开资料整理，不构成投资建议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219042437a4b13bd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219042437a4b13bd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4501","BK4585","BK4548","MRNA","BK4533","BK4588","BK4534","BK4568","BK4551","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612441990","title":"美股异动丨莫德纳(MRNA.US)涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612441990","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612441990?lang=zh_cn&edition=full","pubTime":"2026-02-18 22:36","pubTimestamp":1771425360,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4588","BK4568","MNQmain","TZA","BK4551","BK4532","MRNA","BK4534","BK4581","UWM","SRTY","BK4548","IWN","BK4139","BK4535","TNA","RWM","BK4585","BK4501","BK4550","IWO","TWM","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612405912","title":"莫德纳盘中异动 早盘股价大涨6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612405912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612405912?lang=zh_cn&edition=full","pubTime":"2026-02-18 22:31","pubTimestamp":1771425070,"startTime":"0","endTime":"0","summary":"北京时间2026年02月18日22时31分，莫德纳股票出现异动，股价大幅拉升6.01%。截至发稿，该股报46.57美元/股，成交量110.469万股，换手率0.28%，振幅1.47%。莫德纳股票所在的生物技术行业中，整体跌幅为0.48%。莫德纳公司简介：莫德纳是一家商业阶段的生物技术公司，成立于 2010 年，并于 2018 年 12 月首次公开募股。截至 2025 年 8 月，莫德纳有 35 种 mRNA 开发候选药物处于临床研究中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218223110a7077586&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218223110a7077586&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4533","BK4548","BK4501","BK4551","BK4534","BK4532","MRNA","BK4585","SNSE","BK4588","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1131104661","title":"FDA同意审查Moderna季节性流感疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=1131104661","media":"老虎资讯综合","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131104661?lang=zh_cn&edition=full","pubTime":"2026-02-18 20:52","pubTimestamp":1771419126,"startTime":"0","endTime":"0","summary":"此前该公司宣布美国食品药品监督管理局已同意审查其在研季节性流感疫苗mRNA-1010的生物制品许可申请。FDA的这一决定是在A类会议后做出的,Moderna在会上提出了该候选疫苗的修订监管方案。Moderna的修订方案寻求对50至64岁成年人的完全批准,以及对65岁及以上人群的加速批准,并承诺在上市后要求中对老年人进行额外研究。Moderna预计mRNA-1010将在2026年获得首批潜在批准,具体取决于各个市场正在进行的监管审查。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8e8e39a7beb148acde163c9bfa12c7e1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"FDA同意审查Moderna季节性流感疫苗","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2612059454","title":"格隆汇2月18日 Moderna总裁表示希望秋季能将流感疫苗推向市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2612059454","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612059454?lang=zh_cn&edition=full","pubTime":"2026-02-18 20:49","pubTimestamp":1771418940,"startTime":"0","endTime":"0","summary":"2月18日格隆汇消息，Moderna总裁称期望在秋季把流感疫苗推向市场。这一表态体现了Moderna在疫苗研发与推广上的积极进展与规划，流感作为常见且影响广泛的疾病，每年都会给公众健康带来较大威胁，有效流感疫苗的及时供应对于预防流感、降低感染率、减轻医疗系统负担意义重大。Moderna作为在疫苗领域具有重要影响力的企业，其流感疫苗若能在秋季顺利推向市场，有望为全球流感防控工作提供新的有力武器，为公众健康增添保障，也显示出该企业在应对公共卫生挑战方面的积极作为与责任担当，后续其疫苗研发进展及市场推广情况值得持续关注。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218205117a7073830&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218205117a7073830&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4501","BK4588","MRNA","BK4139","BK4533","BK4532","BK4551","BK4568","BK4548","BK4534","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.modernatx.com;www.investors.modernatx.com","stockEarnings":[{"period":"1week","weight":-0.0816},{"period":"1month","weight":-0.0126},{"period":"3month","weight":0.5943},{"period":"6month","weight":0.7269},{"period":"1year","weight":0.7749},{"period":"ytd","weight":0.6684}],"compareEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":-0.036},{"period":"3month","weight":-0.04},{"period":"6month","weight":-0.02},{"period":"1year","weight":0.1617},{"period":"ytd","weight":-0.0383}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Moderna, Inc.于2016年7月22日根据特拉华州法律注册成立。该公司是信使核糖核酸（信使核糖核酸）医学领域的领导者。通过在科学、技术和健康的交叉领域工作十多年，该公司以前所未有的速度和效率开发出药物，包括最早和最有效的新冠疫苗之一。该公司的mRNA平台已使传染病、免疫肿瘤学、罕见病和自身免疫性疾病的疗法和疫苗的开发成为可能。凭借独特的文化和由Moderna价值观和思维模式驱动的全球化团队，以负责任的方式改变人类健康的未来，该公司努力通过mRNA药物向人们传递尽可能大的影响。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.112326},{"month":2,"riseRate":0.375,"avgChangeRate":0.016129},{"month":3,"riseRate":0.5,"avgChangeRate":0.01856},{"month":4,"riseRate":0.625,"avgChangeRate":0.104523},{"month":5,"riseRate":0.571429,"avgChangeRate":0.06219},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.025027},{"month":7,"riseRate":0.714286,"avgChangeRate":0.106584},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.089569},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.018964},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.032236},{"month":11,"riseRate":0.714286,"avgChangeRate":0.206001},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.033274}],"exchange":"NASDAQ","name":"Moderna, Inc.","nameEN":"Moderna, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Moderna, Inc.,MRNA,Moderna, Inc.股票,Moderna, Inc.股票老虎,Moderna, Inc.股票老虎国际,Moderna, Inc.行情,Moderna, Inc.股票行情,Moderna, Inc.股价,Moderna, Inc.股市,Moderna, Inc.股票价格,Moderna, Inc.股票交易,Moderna, Inc.股票购买,Moderna, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}